Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyModa Health Intrathecal Pump Prior Auth | OpenPaye…
    Ask Trek AI about this page
    CurrentModa HealthPolicy N/A

    Intrathecal Opioid Infusion Pump Therapy for Management of Chronic Pain

    Customize your policy alerts

    Sign up for all Moda Health policy alerts

    Know when Moda Health releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs Moda Health coverage and prior authorization for trial and permanent implantation of intrathecal or epidural opioid infusion pumps for chronic pain. Coverage applies when documented pathology, failed conservative treatment, specialist evaluation, psychological clearance when applicable, and a successful trial response meet the stated criteria.

    Policy Summary
    PayerModa Health
    PolicyIntrathecal Opioid Infusion Pump Therapy for Management of Chronic Pain
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateSep 1, 2026
    Last ReviewAug 26, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization and submit the treating physician's history and physical, conservative treatment history and results, current activity level, and documented trial response when applicable.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    50%Required pain reduction for permanent pump placement
    6

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Conservative treatment categories to try when appropriate
    9Contraindication categories
    24Annual review history entries through August 2026
    F (2 & 3)CMS jurisdiction

    Coverage Criteria

    Implantable Infusion Pump Trial

    Moda Health covers a trial of an implantable infusion pump for pain management when <strong>all</strong> of the following criteria are met:

    ALL of the following

    • The device has FDA approval and is used specifically for the FDA-approved purpose.
    • The drugs used to fill the implantable pump are appropriate for treating the individual patient.
    • Administration of the medication can reasonably be expected to alleviate or reduce the effects of the patient's pain.
    • Administration of the opioid drugs, alone or in combination with other opioid or nonopioid drugs, requires the intrathecal or epidural route and is expected to be effective on a long-term basis.
    • The patient has demonstrable pathology, established through diagnostic testing, that is related to the patient's pain complaints.
    • Specialist evaluation and failed conservative treatment

      • An orthopedic surgeon, neurologist, neurosurgeon, oncologist, or other specialist familiar with the underlying disease has evaluated the patient and validated that other treatments have failed to alleviate the pain, no other reasonable options are available at the time of evaluation, and all other appropriate methods of pain control or pain management have been tried and proven ineffective or complicated by unacceptable side effects.
      • Physical therapy or exercise programs have been tried and proven ineffective or complicated by unacceptable side effects.
      • Rest and relaxation have been tried and proven ineffective or complicated by unacceptable side effects.
      • Oral or transdermal pain medications have been tried and proven ineffective or complicated by unacceptable side effects.
      • Non-prescription analgesics and anti-inflammatories have been tried and proven ineffective or complicated by unacceptable side effects.
    • The patient has completed a psychological evaluation with clearance for a non-cancer-related indication.
    • Surgical intervention is not indicated.
    • There is no known obstruction to cerebral spinal fluid flow.

    Permanent Implantable Infusion Pump Placement

    Moda Health covers permanent placement of an implantable infusion pump when <strong>all</strong> of the following are met:

    ALL of the following

    • All criteria for the implantable infusion pump trial are met.
    • A positive response to an intrathecal opioid infusion trial is documented, demonstrated by the ability to conduct usual daily activities with a 50% reduction in pain.50% reduction in pain

    Contraindications

    Coverage is excluded when <strong>any</strong> of the following contraindications applies:

    ANY of the following

    • The patient has another implanted programmable device, and crosstalk between the devices may inadvertently change the prescription.
    • The patient's body size is insufficient to support the bulk and weight of the device.
    • The patient has a known allergy or hypersensitivity to the drug being used.
    • The patient has an active infection that may increase the risk associated with the implantable infusion pump.
    • The patient has a history of drug abuse or addiction; active psychosis or suicidality; untreated major depression or mood disorder; or compromised reasoning, judgment, or memory.

    Coverage applies to an implantable infusion pump trial only when the device, medication, route of administration, documented pathology, specialist evaluation, failed prior pain-management methods, psychological clearance when applicable, surgical status, and cerebral spinal fluid flow requirements are all satisfied. A known obstruction to cerebral spinal fluid flow or an indication for surgical intervention does not meet the coverage criteria.

    Permanent pump placement requires fulfillment of the trial criteria plus documentation of a positive intrathecal opioid infusion trial, including the ability to conduct usual daily activities with a 50% reduction in pain. The pump and its use must remain consistent with FDA approval, appropriate patient-specific medication selection, and the applicable implantable-pump safety conditions.

    type_text_placeholder

    Coding and Coverage Status

    Covered CPT or HCPC CodesmixedCovered
    36563Insertion of tunneled centrally inserted central venous access device with subcutaneous pump.
    36576Repair of central venous access device, with subcutaneous port or pump, central or peripheral insertion site.
    36578Replacement, catheter only, of central venous access device, with subcutaneous port or pump, central or peripheral insertion site.
    36583Replacement, complete, of a tunneled centrally inserted central venous access device, with subcutaneous pump, through same venous access.
    36590Removal of tunneled central venous access device, with subcutaneous port or pump, central or peripheral insertion.
    62324Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s), including anesthetic, antispasmodic, opioid, steroid, or other solution, not including neurolytic substances; interlaminar epidural or subarachnoid; cervical or thoracic, without imaging guidance.
    62350Implantation, revision or repositioning of tunneled intrathecal or epidural catheter, for long-term medication administration via an external pump or implantable reservoir/infusion pump; without laminectomy.
    62351Implantation, revision or repositioning of tunneled intrathecal or epidural catheter, for long-term medication administration via an external pump or implantable reservoir/infusion pump; with laminectomy.
    62355Removal of previously implanted intrathecal or epidural catheter.
    62361Implantation or replacement of device for intrathecal or epidural drug infusion; nonprogrammable pump.
    1–10 of 20
    1/2
    Applicable Diagnosis Codes including but not limited toICD-10
    G89.0Central pain syndrome.
    G89.21Chronic pain due to trauma.
    G89.22Chronic post-thoracotomy pain.
    G89.28Other chronic postprocedural pain.
    G89.29Other chronic pain.
    G89.3Neoplasm related pain (acute) (chronic).
    G89.4Chronic pain syndrome.
    R25.0Abnormal head movements.
    R25.1Tremor, unspecified.
    R25.2Cramp and spasm.
    1–10 of 12
    1/2
    Pain Reduction for Permanent Pump Placement
    Required pain reduction50% reduction in pain
    Functional responseAbility to conduct usual daily activities
    Applies toPermanent placement of an implantable infusion pump

    Authorization and Documentation Requirements

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required for both the intrathecal opioid infusion pump trial and permanent pump placement. Submit the applicable clinical and treatment-response records with the request.

    • Authorization applies to the pump trial and permanent placement.
    • Required records include clinical eligibility documentation, conservative-treatment history, current activity level, and—when applicable—intrathecal opioid trial results.
    Documentation Required

    Failure of Conservative Treatment

    Document that appropriate pain-control methods were tried and failed to adequately relieve pain or were limited by unacceptable side effects. The record should address physical therapy or exercise, rest and relaxation, oral or transdermal pain medications, non-prescription analgesics or anti-inflammatories, injectable medications, and local or regional blocks or epidural steroid injections.

    Therapy Background

    Intrathecal opioid therapy delivers medication through an implanted infusion pump for patients with chronic, intractable pain. The pump administers medication through an intrathecal or epidural route and may be considered when appropriate pain-management methods have failed or caused unacceptable adverse effects.

    Because pump implantation is invasive and may involve serious device or catheter-related complications, treatment is evaluated in stages. A temporary intrathecal opioid infusion trial precedes permanent placement, and permanent implantation requires documented functional improvement with the ability to conduct usual daily activities and a 50% reduction in pain.

    Definitions

    Positive Intrathecal Opioid Infusion Trial
    Trial outcomePositive response to an intrathecal opioid infusion trial
    Pain reduction50% reduction in pain
    Functional outcomeAbility to conduct usual daily activities
    Implantable Infusion Pump Trial
    PurposePain management
    TimingEvaluated before permanent placement
    DescriptionA trial of an implantable infusion pump

    Conservative Treatment Requirements

    Conservative Treatment Requirements

    Before intrathecal opioid therapy, ALL of the following appropriate methods of pain control or pain management must have been tried and proven ineffective or limited by unacceptable side effects. Document the duration and results of each trial; no minimum duration is specified.

    Conservative treatment history

    • Physical therapy or exercise programs have been tried and proven ineffective or limited by unacceptable side effects.
    • Rest and relaxation have been tried and proven ineffective or limited by unacceptable side effects.
    • Oral or transdermal pain medications have been tried and proven ineffective or limited by unacceptable side effects.
    • Nonprescription analgesics and anti-inflammatories have been tried and proven ineffective or limited by unacceptable side effects.

    Diagnostic Testing Requirements

    Note

    Provide diagnostic testing

    Diagnostic testing is required to demonstrate pathology related to the patient’s pain complaints for the intrathecal opioid pump trial and placement. The policy does not prescribe a particular imaging modality.

    Policy Summary
    PayerModa Health
    PolicyIntrathecal Opioid Infusion Pump Therapy for Management of Chronic Pain
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateSep 1, 2026
    Last ReviewAug 26, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization and submit the treating physician's history and physical, conservative treatment history and results, current activity level, and documented trial response when applicable.
    SourceLink
    On This Page
    Coverage CriteriaCoding and Coverage StatusAuthorization and Documentation RequirementsTherapy BackgroundDefinitionsConservative Treatment RequirementsDiagnostic Testing Requirements
    Injectable pain medications, including intramuscular, subcutaneous, or intravenous injections, have been tried and proven ineffective or complicated by unacceptable side effects.
  1. Local or regional blocks or epidural steroid injections have been tried and proven ineffective or complicated by unacceptable side effects.
  2. Documentation Required

    Initial Prior Authorization Records

    For the initial prior authorization request, submit a complete history and physical from the treating physician and medical records describing conservative therapy trials, their duration, and results. Include documentation of the patient's current activity level.

    • Complete treating-physician history and physical.
    • Conservative-treatment history, duration, and results.
    • Current activity level.
    Documentation Required

    Permanent Placement Trial Documentation

    For permanent pump placement, submit documentation of the patient's response to the intrathecal opioid infusion trial, including functional improvement. Coverage requires documentation that the patient can conduct usual daily activities with a 50% reduction in pain.

    • Intrathecal opioid trial response.
    • Ability to conduct usual daily activities with a 50% reduction in pain.
    Documentation Required

    Clinical Eligibility Documentation

    Document the clinical eligibility requirements supporting the request, including diagnostic evidence of pathology related to the pain, specialist evaluation, failure or intolerance of other reasonable treatment options, and psychological clearance for non-cancer-related indications.

    • Demonstrable pathology related to the pain, established through diagnostic testing.
    • Evaluation by an orthopedic surgeon, neurologist, neurosurgeon, oncologist, or other specialist familiar with the underlying disease.
    • Documentation that other treatments failed or were ineffective or caused unacceptable side effects, and that no other reasonable options are available at the time of evaluation.
    • Completed psychological evaluation with clearance for non-cancer-related indications.
    Denial Risk

    Failure to Meet Medical Necessity Criteria

    The request may be denied when medical-necessity requirements are not met. The device must have FDA approval and be used for its FDA-approved purpose; the drugs must be appropriate for the individual patient; medication administration must reasonably be expected to reduce pain; and the opioid regimen must require the intrathecal or epidural route and be effective on a long-term basis.

    • FDA-approved device used for the FDA-approved purpose.
    • Appropriate medication selection for the individual patient.
    • Reasonable expectation that administration will alleviate or reduce pain effects.
    • Intrathecal or epidural administration required, with long-term effectiveness expected.
    Denial Risk

    Unsuccessful or Undocumented Trial

    Permanent placement may be denied when the required positive intrathecal opioid infusion trial response is absent or not documented. The response must demonstrate the ability to conduct usual daily activities with a 50% reduction in pain.

    • Document a positive intrathecal opioid infusion trial.
    • Document functional response and the 50% pain-reduction threshold.
    Denial Risk

    Contraindications

    Screen for contraindications before requesting implantation. Coverage may be denied when an incompatible implanted programmable device, insufficient body size, drug allergy or hypersensitivity, active infection, or specified substance-use, psychiatric, or cognitive conditions are present.

    • Other implanted programmable devices creating a risk of prescription-changing crosstalk.
    • Body size insufficient to support the device's bulk and weight.
    • Known allergy or hypersensitivity to the drug used.
    • Active infection increasing implantation risk.
    • History of drug abuse or addiction; active psychosis or suicidality; untreated major depression or mood disorder; or compromised reasoning, judgment, or memory.
    Denial Risk

    Clinical Exclusion Conditions

    Coverage criteria are not met when surgical intervention is indicated or when there is a known obstruction to cerebral spinal fluid flow.

    • Surgical intervention is not indicated.
    • No known obstruction to cerebral spinal fluid flow.
  3. Injectable pain medications, including intramuscular, subcutaneous, or intravenous injections, have been tried and proven ineffective or limited by unacceptable side effects.
  4. Local or regional blocks or epidural steroid injections have been tried and proven ineffective or limited by unacceptable side effects.